Primary biliary cirrhosis is an autoimmune liver disease, characterized by the progressive destruction of the small intrahepatic bile duct epithelial cells and the presence of antimithocondrial antibodies (AMA). Ankylosing spondilitis is a systemic, inflammatory, progressive disease, which usually affects the joints of the spine and the sacroiliac joints. The association of these two is very rare, in literature we found only one single study published in 1994, which describes the occurrence of primary biliary cirrhosis accompanying ankylosing spondylitis in a male patient. The aim of our study is to present the case of our patient, who had ankylosing spondylitis and has developed primary biliary cirrhosis. Our patient has ankylosing spondylitis with peripheral joint involvement, so according to the guidelines we initiated treatment with Sulfasalazine. We know from the literature about the hepatotoxicity of Sulfasalazine in some cases, so within each follow-up examination we monitored the liver function tests, and we also performed complete blood counts. The treatment of ankylosing spondylitis is challenging in this case due to the hepatotoxicity of the medications. Besides Sulfasalazine, our patient continued the treatment for primary biliary cirrhosis (ursodeoxycholic acid with hepatoprotective drugs in higher doses).
Introduction
Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by the presence of very specific serum antimitochondrial antibodies (AMA), and by the progressive destruction of intrahepatic bile duct epithelial cells, resulting in chronic cholestasis and fibrosis, which may lead to liver cirrhosis and subsequent hepatic impairment (1) .
It has a prevalence of approximately 150-300 / 1,000,000 patients and involves women in 90% of cases (2) . Diagnosis of primary biliary cirrhosis may be suspected in the presence of chronic cholestasis, excluding other hepatic diseases. The suspected diagnosis is based on cholestatic liver tests, but is confirmed by the presence of AMA (3) .
Primary biliary cirrhosis may be associated with several autoimmune diseases, including Sjögren's syndrome in 70% of patients, autoimmune thyroid disease in about 10% (4) , systemic sclerosis in 15% of cases (5) , and rarely rheumatoid arthritis between 1.8 and 5.6% (6) . Ankylosing spondylitis (AS) is a progressive chronic systemic inflammatory disease that affects the joints of the spine, sacroiliac joints, and surrounding soft tissues. Often, the inflammatory process begins at the sacroiliac joints, subsequently involving the other spinal segments.
Inflammation will be followed by fibrosis and then by bone ankylosis, creating a rigid spinal column (7, 17) . The HLA -B27 phenotype is present in 90% of patients with ankylosing spondylitis (7, 8) . The association of primary biliary cirrhosis with ankylosing spondylitis is very rare, in literature we have found only one published case, in 1994 (9) . In this case study we present the case of a p a t i e n t w i t h a n ky l o s i n g s p o n d y l i t i s associated with primary biliary cirrhosis.
Case presentation
A 56-year-old female patient first admitted to the Rheumatology Clinic in Târgu Mureş in Fe b r u a r y 2 0 1 6 , w i t h t h e f o l l o w i n g complaints: right gonalgia with mixed character dorsalgias, inflammatory lumbar , pain pain in the chondrosternal joints , ,
morning stiffness for about 10 minutes.
Disease history
The patient is known with ankylosing spondylitis since 1990, positive, HLA -B27 
Diagnosis
We 
Differential diagnosis
We have performed the differential diagnosis h) Multiple myeloma -we have not found laboratory tests that correlate with this condition. According to the guidelines, biological therapy is initiated when the disease is active despite the use of Sulfasalazine for more than 4 months. However, the patient refuses biological therapy. Thus, the patient remains o n t r e a t m e n t w i t h S u l f a s a l a z i n e , ursodeoxycholic acid and hepatoprotectors.
Discussions
Primary biliary cirrhosis is often associated with other autoimmune diseases: Sjögren's syndrome, autoimmune thyroid disease (4), systemic sclerosis (5) and, more rarely, rheumatoid arthritis (6) . We found a single article in the literature (1994) describing a case of ankylosing spondylitis associated with primary biliary cirrhosis. Thus, the prevalence of primary biliary cirrhosis associated with ankylosing spondylitis is unknown.
In the peripheral form of ankylosing spondylitis, Sulfasalazine treatment is used according to the guidelines (10, 11, 12) . hepatic or pulmonary dysfunction (13, 18) .
Acute and clinically relevant hepatic injury, secondary to Sulfasalazine treatment, may occur in 1 in 1,000 patients.
Most cases occur in the first month of t r e a t m e n t w i t h S u l f a s a l a z i n e a s a hepatocellular or cholestatic lesion.
Approximately 25% of patients develop jaundice and a certain proportion rapidly develop liver failure (14, 15) . In another study, 
Conclusions
With this paper we wanted to present the case of a patient diagnosed with ankylosing spondylitis in 1990, who after 24 years also developed primary biliary cirrhosis. We have 
